Polish market for clinical trials grows

The Polish market for clinical trials saw an estimated 7% year-on-year growth in 2011, after relatively flat periods in 2009 and 2010. Experts predict that the Polish market's year-to-year expansion will hover around 3% and 4% in 2012 and 2013. The moderate growth indicates that the country remains an attractive destination for clinical trials and research. Story

Suggested Articles

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.